smallcaps.com.au · May 4, 2026 01:03 AM UTC

Entropy Neurodynamics Reports Breakthrough Results from Phase 2a TRP-8802 Study for Treating IBS

Summary

Entropy Neurodynamics announces Phase 2a TRP-8802 IBS results: 75% responders, clear gut-brain axis effect; de-risks program ahead of TRP-8803 trials.

Original reporting

Open original source

Related coverage

Read full article on smallcaps.com.au